Pseudomonas aeruginosa strain GN315, producing kanamycin acetyltransferase, can transmit a plasmid determining resistance to kanamycin, amikacin (BB-K8), butirosin, tobramycin, and sisomicin, but not gentamicin, to other pseudomonas strains. This plasmid, pMG5, belongs to the same incompatibility group as plasmids determining gentamicin resistance in P. aeruginosa via gentamicin acetyltransferase I. Like other members of this group, it also confers resistance to Hg2+, organomercurials, and certain deoxyribonucleic acid phages. When pMG5 is introduced into a cell carrying a related R factor, some transconjugants can subsequently cotransfer new combinations of resistance determinants as though recombinant plasmids had been formed.
Most clinical isolates of Pseudomonas aeruginosa are susceptible to gentamicin and tobramycin, but strains have been found that are gentamicin resistant and tobramycin susceptible, gentamicin and tobramycin resistant, or, least commonly, gentamicin susceptible and tobramycin resistant. These phenotypes can be accounted for by the substrate specificities of known inactivating enzymes in P. aeruginosa (2). Gentamicin acetyltransferase I inactivates gentamicin but has little activity against tobramycin (4). Gentamicin adenylyltransferase is 'active against both drugs (9) , and kanamycin acetyltransferase is active against tobramycin but not against all the components of the gentamicin complex (1).
In some P. aeruginosa strains these inactivating enzymes are determined by transmissible R plasmids. A P. aeruginosa strain inactivating gentamicin by adenylylation can transfer resistance to Escherichia coli (10) where the R factor involved, R64, belongs to incompatibility group C (5, 11). P. aeruginosa strains inactivating gentamicin by acetylation can transfer resistance to other pseudomonas strains but not to E. coli (3, 7) . R factors of this type, such as pMG1, are comp-tible with C-, N-, P-, and W-type R plasmids in P. aeruginosa but not with certain other pseudomonas R plasmids that have been assigned to incompatibility group P-2 (3, 7). In addition to antibiotic resistance, members of the P-2 incompatibility group may confer resistance to mercuric ion, organomercurials, ultraviolet radiation, and certain deoxyribonucleic acid phages and may also inhibit pyocin production (7) .
An R plasmid in P. aeruginosa determining kanamycin acetyltransferase has not yet been reported. This paper describes such an R factor, relates its properties to R plasmids determining other aminoglycoside-inactivating enzymes in pseudomonas, and suggests a way in which new combinations of R factor genes may evolve.
MATERIALS AND METHODS
Most of the strains, media, and techniques have been described previously (7) . P. aeruginosa GN315 was provided by K. E. Price, Bristol Laboratories.
Gentamicins Cl, C., and C2 came from G. H.
Wagman, Schering Corp.
RESULTS
The donor strain P. aeruginosa GN315 was isolated from a patient in Japan by Mitsuhashi (12) and has been shown to produce kanamycin acetyltransferase (13) . The initial recipient strain was ilv leu rif PU21 (7) . Tobramycinresistant transconjugants were selected by using rifampin for counterselection after overnight mating and appeared at a frequency of 10-2 per donor cell. Sulfonamide resistance was acquired concomitantly. The R plasmid involved, pMG5, could be transferred to other P. aeruginosa strains but not to E. coli strains K or C (frequency less than 10-8 per donor).
ANTIMICROB. AG. CHEMOTraR. groups that can be transferred from E. coli (7) and against pMG1 as an example of the P-2 incompatibility group (3, 7) . Plasmid pMG5 transferred to recipient strains carrying P-, C-, W-, or N-type R factors at the same frequency as to R plasmid-negative PUl. Furthermore, these pMG5 transconjugants continued to carry resistance markers determined by the P-, C-, W-, or N-type plasmid resident in the recipients, indicating that pMG5 does not belong to any of these incompatibility groups.
In contrast, with PU1 (pMG1) as recipient, the frequency of pMG5 transfer was decreased . The majority of these transconjugants had lost streptomycin and gentamicin resistance determined by pMG1, suggesting that pMG5 and pMG1 are not able to coexist in the same Other properties of pMG5. pMG5 shares a number of other properties with pMG1. Both fail to transfer to E. coli, both produce Hg2+ resistance, and both inhibit the propagation of certain deoxyribonucleic acid phages (Table 2) . pMG5 differs from pMG1 in not producing ultraviolet light resistance and not inhibiting pyocin production. Also, pMG5 confers resistance to phenylmercuric nitrate, as does another member of the P-2 incompatibility group but not pMG1 (7) .
Phenotypes of pMG5 pMGI recombinants. In the cross between PU21 (pMG5) and PUl (pMG1), 8 of 20 transconjugants retained antibiotic resistance markers determined by pMG1 (Table 1) . These 20 transconjugants were examined in greater detail for other properties that distinguish the two plasmids. Phenylmercuric nitrate resistance could not be tested since the FP2 sex factor in PUl itself confers phenylmercuric nitrate resistance.
Six phenotypes could be distingushed from the patterns of antibiotic resistance and inhibition of pyocin production exhibited by these transconjugants (Table 3) . Some retained both gentamicin and streptomycin resistance and some either streptomycin or gentamicin resistance, although most were susceptible to both antibiotics. None were ultraviolet light resistant but three failed to produce pyocin.
Representatives of each type were crossed to another recipient. In each case all properties were cotransferred regardless of which antibiotic (for those resistant to more than tobramycin) was used for selection. These genetic tests suggest that in the original pMG5 x pMG1 cross incompatibility was expressed either by loss of pMG1 or by the formation of recombinant plasmids carrying various combinations of parental genes. Ultraviolet light (UV) resistance was determined from survival curves at a UV dose of 9.2 ergs per mm2 per 8.
Resistance to pseudomonas phages B3, D3, E79, G101, PBl, and M6 was tested by quantitative plate counts. PU21 is sensitive to each of these phases, but none propagate on these R+ derivatives.
c Pyocin production was determined by the Gullies and Govan technique (6).
P. AERUGINOSA R PLASMID 809 a Tobramycin-resistant transconjugants in the cross PU21 (pMG5) x PUl (pMG1) of Table 1 were purified and tested for the indicated properties. Abbreviations: GM, Gentamicin; SM, streptomycin; UV, ultraviolet light.
Spectrum of amihoglycoside resistance. The spectrum of aminoglycoside resistance produced by pMG5 is shown in Table 4 . As expected from the substrate specificity of kanamycin acetyltransferase (1, 2), pMG5 conferred resistance to kanamycin, amikacin (BB-K8), butirosin, gentamicin B (Sch 14342), sisomicin, and tobramycin. It provided resistance to gentamicin C15, slight resistance to gentamicin C2, but no resistance to gentamicin Cl and hence did not significantly enhance resistance to the gentamicin complex. Data for pMG1 and R64 are indicated for comparison. Each of these plasmids conferred resistance to gentamicin Cl, Cia, and C2, but neither provided resistance to amikacin or butirosin. DISCUSSION The R plasmid described here, pMG5, originated in a strain known to produce kanamycin acetyltransferase (13) and confers on its host resistance to those aminoglycosides with a free 6'-amino group whose acetylation results in loss of antibiotic activity (1). Thus, in addition to kanamycin resistance, pMG5 confers resistance to amikacin, butirosin, gentamicin B (Sch 14342), sisomicin, and tobramycin (Table 4) as expected from the in vitro activity of extracts of its parent strain toward aminoglycoside antibiotics (8, 12, 13) . At present clinical P. aeruginosa isolates with this resistance pattern are uncommon, but as these new aminoglycosides come into broader use, such R plasmids will provide one mechanism for the emergence of resistant strains.
pMG5, which was discovered in a P. aeruginosa strain from Japan, appears to belong to the same incompatibility group as R plasmids discovered in resistant pseudomonas strains from Atlanta, Capetown, and Canada (7) 
